OMERS ADMINISTRATION Corp Invests $7.75 Million in CVS Health Corporation $CVS

OMERS ADMINISTRATION Corp bought a new position in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, Holdings Channel reports. The fund bought 74,907 shares of the pharmacy operator’s stock, valued at approximately $7,749,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Kilter Group LLC purchased a new stake in CVS Health during the second quarter valued at about $27,000. Beaird Harris Wealth Management LLC increased its position in shares of CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 195 shares in the last quarter. J.Safra Asset Management Corp purchased a new stake in shares of CVS Health in the 2nd quarter valued at approximately $30,000. Dunhill Financial LLC purchased a new stake in shares of CVS Health in the 2nd quarter valued at approximately $32,000. Finally, Swiss RE Ltd. acquired a new position in CVS Health in the 4th quarter worth approximately $26,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CVS. Truist Financial upped their price target on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Royal Bank Of Canada upped their target price on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a report on Thursday, July 9th. Mizuho increased their price target on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Deutsche Bank Aktiengesellschaft raised their price target on shares of CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Finally, UBS Group increased their target price on shares of CVS Health from $122.00 to $126.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Twenty-two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Stock Up 1.1%

CVS stock opened at $94.06 on Tuesday. The firm has a market cap of $120.31 billion, a PE ratio of 24.88, a PEG ratio of 0.85 and a beta of 0.61. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The company has a fifty day simple moving average of $101.88 and a 200 day simple moving average of $89.08. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same period last year, the company earned $1.81 earnings per share. The business’s revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date was Thursday, July 23rd. CVS Health’s payout ratio is presently 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.